To ask the Secretary of State for Health with reference to the Written Ministerial Statement of 8 March 2008, Official Report, column 121WS, on GlaxoSmithKline (MHRA investigation), what discussions he has had with the Chief Executive of the Medicines and Healthcare Regulatory Authority on its investigation of the trials of Seroxat involving children between 1994 and 2002. (196777)

[holding answer 25 March 2008]: Departmental Ministers were briefed on a regular basis on the progress of the investigation into the compliance of GlaxoSmithKline with relevant legislation, and on the conclusion of the investigation, in advance of the written ministerial statement.